DeepMed Research

ICAHN School of Medicine At Mount Sinai

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1963-01-01

Employees: 5K

Market Cap: -

Website: http://www.mssm.edu

Clinical Trials

Metabolism of Bioactive Dietary Polyphenol Preparation (BDPP)

Phase 1

Completed

Conditions: Healthy Control

Interventions: Dietary Supplement: Trans-resveratrol
Drug: Placebo
Dietary Supplement: Concord grape juice
Dietary Supplement: Grape seed polyphenol extract

First Posted Date: 2020-06-09

Last Posted Date: 2025-03-03

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 84

Registration Number: NCT04421079

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Abdominal Binder and Steps Trial

Not Applicable

Completed

Conditions: Post-operative Milestones

Interventions: Other: Step Counter
Other: Abdominal Binder

First Posted Date: 2020-06-04

Last Posted Date: 2024-08-15

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 85

Registration Number: NCT04414384

Locations: 🇺🇸
Mount Sinai Hospital, New York, New York, United States

Self-Control in Bulimia Nervosa

Not Applicable

Completed

Conditions: Bulimia Nervosa

Interventions: Other: fasting state
Other: fed state
Other: magnetic resonance imaging

First Posted Date: 2020-06-01

Last Posted Date: 2025-01-30

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 60

Registration Number: NCT04409457

Locations: 🇺🇸
Center of Excellence in Eating and Weight Disorders at the Icahn School of Medicine at Mount Sinai, New York, New York, United States

Myocardial Injury and Major Adverse Outcomes in Patients With COVID-19

Completed

Conditions: COVID-19
Myocardial Reperfusion Injury
Cardiovascular Diseases

First Posted Date: 2020-05-21

Last Posted Date: 2024-03-08

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 4695

Registration Number: NCT04397939

Locations: 🇺🇸
Mount Sinai Hospital, New York, New York, United States

Early CPAP in COVID-19 Confirmed or Suspected Patients

Not Applicable

Terminated

Conditions: COVID-19
COVID
Coronavirus

Interventions: Device: Continuous Positive Airway Pressure

First Posted Date: 2020-05-15

Last Posted Date: 2022-09-28

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 4

Registration Number: NCT04390191

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Interferon Lambda Therapy for COVID-19

Phase 2

Withdrawn

Conditions: SARS-CoV-2

Interventions: Drug: Peginterferon Lambda-1A

First Posted Date: 2020-05-14

Last Posted Date: 2021-02-26

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Registration Number: NCT04388709

MSCs in COVID-19 ARDS

Phase 3

Terminated

Conditions: Remestemcel-L
Acute Respiratory Distress Syndrome
COVID
Mesenchymal Stromal Cells

Interventions: Biological: Remestemcel-L
Drug: Placebo

First Posted Date: 2020-05-01

Last Posted Date: 2022-04-25

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 223

Registration Number: NCT04371393

Locations: 🇺🇸
Maine Medical Center, Portland, Maine, United States
🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸
University of Michigan, Ann Arbor, Michigan, United States

and more 18 locations

Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV

Phase 1

Conditions: HIV
Non-HIV
Vagus Nerve Dysfunction

Interventions: Drug: Pyridostigmine
Drug: Placebos
Procedure: non-invasive vagal nerve stimulation

First Posted Date: 2020-04-20

Last Posted Date: 2025-02-11

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 55

Registration Number: NCT04353778

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Translating Scientific Evidence Into Practice Using Digital Medicine and Electronic Patient Reported Outcomes

Not Applicable

Active, not recruiting

Conditions: Inflammatory Bowel Disease (IBD)

Interventions: Behavioral: Digital Transformation Network (DTN) Program

First Posted Date: 2020-04-14

Last Posted Date: 2024-08-20

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 614

Registration Number: NCT04345393

Locations: 🇺🇸
University of California, Davis, Davis, California, United States
🇺🇸
RxHealth, Secaucus, New Jersey, United States
🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

and more 1 locations

Nitropaste in Breast Reduction

Phase 3

Withdrawn

Conditions: Delayed Wound Healing
Gynecomastia

Interventions: Drug: Nitroglycerin Paste
Drug: Dermabond

First Posted Date: 2020-03-26

Last Posted Date: 2022-11-08

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Registration Number: NCT04321967

Locations: 🇺🇸
Mount Sinai Hospital, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy